VINCEL CORDRY: Open Payments
NPI 1750359311 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 8 payments from 6 companies in 2025. Trend: 2023 $182 · 2024 $372 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: REXULTI, ARISTADA, Qelbree, ABILIFY ASIMTUFII, COBENFY, AUSTEDO XR.
Industry payments across OK — which companies pay providers there.
